Index Venture Associates III Ltd

Index Venture Associates III Ltd has filed trades across 3 companies (mainly through SEC (Form 4)), most often in Egalet Corp, Minerva Neurosciences, Inc. and Aegerion Pharmaceuticals, Inc. Between 27 October 2010 and 24 June 2019, the trades on record add up to 62 filings.

In open-market terms, that means 9 purchases worth €13.5M on one side and 21 sales worth €23.1M on the other. On balance, insiders were net sellers of €9.6M. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Outside the open market, there are 6 share grants. In 2019 alone, the filings show no purchases and 14 sales.

A typical purchase (the median) is worth €920k. For 3 purchases whose 90-day window has closed, the share price was higher on day 90 than the day after publication in 0% of cases, with a median move of -22.8%. Past outcomes like these are no guarantee of what comes next.

The newest entry dates from 26 June 2019: an open-market sale of €1.0M, in Minerva Neurosciences, Inc. The latest purchase dates back some time: it was published 4,251 days ago, on 20 March 2015. Typically, a trade is published a median of 2 days after it takes place. US insiders must file a Form 4 within two business days of a trade. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.